A single centre, randomised, double-blind, placebo-controlled, parallel group study to evaluate efficacy of PR [prolonged release] OROS methylphenidate and psychosocial interventions, with open-label extension, in Swedish imprisoned adult men with ADHD.

Trial Profile

A single centre, randomised, double-blind, placebo-controlled, parallel group study to evaluate efficacy of PR [prolonged release] OROS methylphenidate and psychosocial interventions, with open-label extension, in Swedish imprisoned adult men with ADHD.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Aug 2015

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2015 3-year follow-up results published in the Journal of Clinical Psychopharmacology.
    • 11 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Aug 2009 Trial phase changed from IV to III as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top